학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 82건 | 목록 1~20
Report
Phys. Rev. Applied 18, 034058 (2022)
Academic Journal
APL Quantum, Vol 1, Iss 4, Pp 046106-046106-10 (2024)
Academic Journal
Bonhof A; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Hiensch AE; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Wierdsma NJ; Department of Nutrition and Dietetics, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.; Huis In 't Veld LF; Department of Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.; Bakker SD; Department of Medical Oncology, Zaans Medical Center, Zaandam, The Netherlands.; Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands.; Davidis-van Schoonhoven M; Department of Medical Oncology, Beatrix Hospital, Gorinchem, The Netherlands.; Droogendijk H; Department of Internal Medicine, Bravis Hospital, Bergen op Zoom, The Netherlands.; Drooger JC; Department of Medical Oncology, Ikazia Hospital, Rotterdam, The Netherlands.; Douma JAJ; Department of Medical Oncology, Frisius Medical Center, Leeuwarden, The Netherlands.; Goedegebuure RSA; Department of Internal Medicine, Meander Medical Center, Amersfoort, The Netherlands.; Haj Mohammad N; Department of Medical Oncology, Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; van Hellemond IEG; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Herbschleb K; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein, The Netherlands.; Janssen JJB; Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.; Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute University Medical Center, Rotterdam, The Netherlands.; Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Sommeijer D; Department of Medical Oncology, Flevoziekenhuis, Almere, The Netherlands.; Timmermans L; Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.; Verschoor AJ; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, The Netherlands.; de Weger VA; Department of Medical Oncology, Haga Hospital, Den Haag, The Netherlands.; Westdorp H; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Wumkes ML; Department of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.; May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; van Laarhoven HWM; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE
Academic Journal
van Kan AHE; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands.; Harmsze AM; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands.; Herbschleb K; Department of Internal Medicine, St. Antonius Hospital, Utrecht, The Netherlands.; van den Broek MPH; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands.; Department of Pharmaceutics, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Menzer C; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.; Dugas-Breit S; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ and University Hospital Heidelberg, Heidelberg, Germany.; Dugas M; Institute of Medical Informatics, Heidelberg University Hospital, Heidelberg, Germany.; Blank CU; Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Groen EJ; Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Reijers I; Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Schlaak M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.; Eckardt J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.; Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht Cancer Center, Utrecht University, Utrecht, the Netherlands.; Zimmer L; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, and National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany.; Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Franklin C; Department of Dermatology and Venereology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Meiss F; Department of Dermatology and Venereology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.; Schilling B; Department of Dermatology, Venerology and Allergology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany; Department of Dermatology, University Hospital Wuerzburg, Wuerzburg, Germany.; Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the National Center for Tumor Diseases and University Cancer Centre Dresden, Dresden, Germany.; Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum, Minden, Germany; Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.; Thoms KM; Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany.; Haalck T; University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Müller M; German Cancer Research Center DKFZ, Division of Biostatistics, Heidelberg, Germany.; Kopp-Schneider A; German Cancer Research Center DKFZ, Division of Biostatistics, Heidelberg, Germany.; Carlino MS; Melanoma Institute Australia, The University of Sydney, Australia; Department of Medical Oncology Westmead and Blacktown Hospitals, Sydney, Australia.; Long GV; Melanoma Institute Australia, The University of Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, The University of Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.; van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; de Groot JWB; Medical Oncology, Oncology Center, Isala Zwolle, Zwolle, the Netherlands.; Eigentler T; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany; Department of Dermatology, Center for Dermatooncology, University Medical Center Tübingen, Tübingen, Germany.; Stevense-den Boer M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.; Pföhler C; Department of Dermatology, Saarland University Medical Center, Homburg, Saar, Germany.; Herbschleb K; Medical Oncology, Radboudumc, Nijmegen, the Netherlands.; Hassel JC; Heidelberg University, Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases (NCT), NCT Heidelberg, A Partnership Between DKFZ and University Hospital Heidelberg, Heidelberg, Germany. Electronic address: jessica.hassel@med.uni-heidelberg.de.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Conference
Plummer, ER, Dean, E, Evans, J, Greystoke, A, Herbschleb, K, Ranson, M, Brown, J, Zhang, Y, Karan, S, Pollard, J, Penney, MS, Asmal, M & Middleton, MR 2016, Phase I trial of first-in-class ATR inhibitor VX-970 in combination with gemcitabine (Gem) in advanced solid tumors (NCT02157792). in Journal of Clinical Oncology. 15_suppl 2513 edn, vol. 34, ASCO annual conference 2016, Chicago, United States, 3/06/16.
Academic Journal
van Zeijl, M C T, Wouters, M W J M, van den Eertwegh, A J, Aarts, M J, van Akkooi, A C J, van den Berkmortel, F W P J, Franken, M G, de Groot, J W B, Herbschleb, K H, van der Hoeven, J J M, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, Van der Veldt, A A M, Vreugdenhil, G & Haanen, J B A G 2018, 'Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii455. https://doi.org/10.1093/annonc/mdy289.032
Academic Journal
Menzer C; Heidelberg University Hospital, Heidelberg, Germany.; Memorial Sloan Kettering Cancer Center, New York, NY.; Menzies AM; The University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.; Carlino MS; The University of Sydney, Sydney, NSW, Australia.; Crown Princess Mary Cancer Centre Westmead, Sydney, NSW, Australia.; Reijers I; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Groen EJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Eigentler T; University Medical Center Tübingen, Tübingen, Germany.; de Groot JWB; Isala Zwolle, Zwolle, the Netherlands.; van der Veldt AAM; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Johnson DB; Vanderbilt University Medical Center, Nashville, TN.; Meiss F; Medical Center-University of Freiburg and University of Freiburg, Freiburg, Germany.; Schlaak M; University Hospital Cologne, Cologne, Germany.; University Hospital, LMU Munich, Munich, Germany.; Schilling B; University Hospital Würzburg, Würzburg, Germany.; Westgeest HM; Amphia Hospital, Breda, the Netherlands.; Gutzmer R; Hannover Medical School, Hannover, Germany.; Pföhler C; Saarland University Medical Center, Homburg/Saar, Germany.; Meier F; Dresden University Hospital, Dresden, Germany.; Zimmer L; University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Suijkerbuijk KPM; University Medical Center Utrecht Cancer Center, Utrecht, the Netherlands.; Haalck T; University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Thoms KM; University Medical Center Göttingen, Göttingen, Germany.; Herbschleb K; Radboudumc, Nijmegen, the Netherlands.; Leichsenring J; Heidelberg University Hospital, Heidelberg, Germany.; Menzer A; University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Kopp-Schneider A; German Cancer Research Center, Heidelberg, Germany.; Long GV; The University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.; Kefford R; The University of Sydney, Sydney, NSW, Australia.; Macquarie University, Sydney, NSW, Australia.; Enk A; Heidelberg University Hospital, Heidelberg, Germany.; Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Hassel JC; Heidelberg University Hospital, Heidelberg, Germany.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
van Loenhout, C.J.van der Leest, C.H.Becker-Commissaris, A.Borgers, J.S.W.Terhegggen, F.van den Borne, B.E.E.M.van Warmerdam, L.J.C.van Leeuwen, L.van der Meer, F.S.Tiemessen, M.A.van Diepen, D.M.Klaver, Y.Hamberg, A.P.Libourel, E.J.Strobbe, L.Cloos, M.Geraedts, E.J.Drooger, J.C.Heller, R.de Groot, J.W.B.Stigt, J.A.Nuij, V.J.A.A.Pitz, C.C.M.Slingerland, M.Borm, F.J.Haberkorn, B.C.M.Westeinde, S.C. van 'tAarts, M.J.B.van Putten, J.W.G.Youssef, M.Cirkel, G.A.Herder, G.J.M.van Rooijen, C.R.Citgez, E.Barlo, N.P.Scholtes, B.M.J.Koornstra, R.H.T.Claessens, N.J.M.Faber, L.M.Rikers, C.H.van de Wetering, R.A.W.Veurink, G.L.Bouter, B.W.Houtenbos, I.Bard, M.P.L.Herbschleb, K.H.Kastelijn, E.A.Brocken, P.Douma, G.Jalving, M.Hiltermann, T.J.N.Schuurbiers-Siebers, O.C.J.Suijkerbuijk, K.P.M.van Lindert, A.S.R.van de Wouw, A.J.van den Boogaart, V.E.M.Bakker, S.D.Looysen, E.Peerdeman, A.L.de Jong, W.K.Siemerink, E.J.M.Staal, A.J.Franken, B.van Geffen, W.H.Bootsma, G.P.de Joode, KarlijnDumoulin, Daphne W.Tol, JolienWestgeest, Hans M.Beerepoot, Laurens V.van den Berkmortel, Franchette W.P.J.Mutsaers, Pim G.N.J.van Diemen, Nico G.J.Visser, Otto J.Oomen-de Hoop, EstherBloemendal, Haiko J.van Laarhoven, Hanneke W.M.Hendriks, Lizza E.L.Haanen, John B.A.G.de Vries, Elisabeth G.E.Dingemans, Anne-Marie C.van der Veldt, Astrid A.M.
In European Journal of Cancer December 2020 141:171-184
검색 결과 제한하기
제한된 항목
[검색어] Herbschleb K
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어